Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Basal Cell Carcinoma (BCC)”

436 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 436 results

Testing effectiveness (Phase 2)Study completedNCT00101348
What this trial is testing

Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+64 more
National Cancer Institute (NCI) 66
Not applicableStudy completedNCT02902822
What this trial is testing

Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of Bergamo

Who this might be right for
ErysipelasImpetigoHerpes Zoster+7 more
Centro Studi Gised 461
Testing effectiveness (Phase 2)Looking for participantsNCT06981325
What this trial is testing

Evaluation of Efficacy and Safety of Cemiplimab as First Line Treatment for Advanced Basal Cell Carcinoma (BCC) Patients

Who this might be right for
Basal Cell Carcinoma (BCC)First Line Treatment
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 34
Not applicableEnded earlyNCT04688749
What this trial is testing

Use of Electrical Impedance Spectroscopy (EIS) for Early Diagnosis of Skin Damage

Who this might be right for
Melanoma (Skin)Basal Cell CarcinomaSquamous Cell Carcinoma+5 more
Aristotle University Of Thessaloniki 50
Not applicableStudy completedNCT00002520
What this trial is testing

Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+7 more
Eastern Cooperative Oncology Group 434
Not applicableStudy completedNCT04795297
What this trial is testing

Observational Study of Correlation Between Recurrent Basal Cell Carcinoma and Localisation

Who this might be right for
Basal Cell Carcinoma
University Hospital, Montpellier 804
Post-approval studies (Phase 4)Study completedNCT02436408
What this trial is testing

VISmodegib for ORbital and Periocular Basal Cell Carcinoma

Who this might be right for
Carcinoma, Basal Cell
University of Michigan Rogel Cancer Center 35
Testing effectiveness (Phase 2)Looking for participantsNCT06624475
What this trial is testing

Neoadjuvant Nivolumab + Relatlimab (Opdualag) Versus Nivolumab for Resectable High-Risk Basal Cell Carcinoma

Who this might be right for
Basal Cell Carcinoma
University of California, San Diego 30
Not applicableEnded earlyNCT01096381
What this trial is testing

Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor

Who this might be right for
Breast CancerCardiovascular ComplicationsColorectal Cancer+6 more
Vanderbilt-Ingram Cancer Center 8
Not applicableEnded earlyNCT03420846
What this trial is testing

Efficiency of Presurgical Basal Cell Carcinoma Margin Mapping

Who this might be right for
Carcinoma, Basal Cell
Michelson Diagnostics Ltd. 86
Testing effectiveness (Phase 2)Study completedNCT01806675
What this trial is testing

18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+41 more
Sanjiv Sam Gambhir 25
Not applicableWithdrawnNCT04093401
What this trial is testing

The VIDYA Study-designed to Determine if Patients With a History of Basal Cell Carcinoma Are More Inclined to Return for Follow-up if Their Risk of a Subsequent Basal Cell Carcinoma is Quantitated.

Who this might be right for
Basal Cell Carcinoma
University of Wisconsin, Madison
Not applicableLooking for participantsNCT06919809
What this trial is testing

Effectiveness and Safety of X A-DERM™ Microsurfaced Acellular Dermal Matrix for Wound Healing After MOHS Surgery

Who this might be right for
Wound Healing After MMS SurgeryBCC - Basal Cell CarcinomaSCC - Squamous Cell Carcinoma+1 more
McGuire Institute 16
Early research (Phase 1)UnknownNCT03982212
What this trial is testing

A Window of Opportunity Trial of Intratumoral Injection of Copaxone® in Patients With Percutaneously Accessible Tumors

Who this might be right for
Cutaneous Squamous Cell CarcinomaSquamous Cell CarcinomaBasal Cell Carcinoma
University of Kansas Medical Center 10
Not applicableStudy completedNCT01872130
What this trial is testing

Reflectance Confocal Microscopy of Wounds During Moh's Surgery: Feasibility Testing of a Mosaicing Algorithm for Intraoperative Imaging of Cancer Margins

Who this might be right for
Basal Cell CarcinomaSquamous Cell Carcinoma
Memorial Sloan Kettering Cancer Center 45
Not applicableStudy completedNCT04936932
What this trial is testing

Laser Treatment of Basal Cell Carcinoma

Who this might be right for
Basal Cell Carcinoma
Sciton 3
Large-scale testing (Phase 3)Study completedNCT01260987
What this trial is testing

Fractional CO2 Laser Assisted Photodynamic Therapy

Who this might be right for
Actinic KeratosisBasal Cell Carcinoma
Bispebjerg Hospital 47
Not applicableStudy completedNCT00897793
What this trial is testing

Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+2 more
Vanderbilt-Ingram Cancer Center 25
Early research (Phase 1)Active Not RecruitingNCT03816332
What this trial is testing

Tacrolimus, Nivolumab, and Ipilimumab in Treating Kidney Transplant Recipients With Selected Unresectable or Metastatic Cancers

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+18 more
National Cancer Institute (NCI) 12
Not applicableStudy completedNCT00476905
What this trial is testing

Spectral Diagnosis of Cutaneous Malignancy

Who this might be right for
Skin Cancer
M.D. Anderson Cancer Center 350
Load More Results